Latest news
Corticosteroids, RAS Inhibitors, or Sparsentan First for FSGS? - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 06 Aug 2026 13:56:38 GMTInside the DUPLEX Trial: FSGS Design, Endpoints, and Exclusions - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 06 Aug 2026 12:14:52 GMTFSGS Pathophysiology: Podocyte Injury Across the Lifespan - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 30 Jul 2026 12:12:31 GMTFSGS Subtypes and Genetics: Why Classification Still Falls Short - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 30 Jul 2026 12:12:31 GMTDimerix to Present Phase 3 FSGS Trial Update and Acute Kidney Injury Program at TechKnow Invest Conference - KalkineKalkine · Mon, 27 Jul 2026 07:00:00 GMT